IL144156A0 - Use of imidazo [1,5-a]-pyrido [3,2-e] -pyrazinones as medicaments - Google Patents
Use of imidazo [1,5-a]-pyrido [3,2-e] -pyrazinones as medicamentsInfo
- Publication number
- IL144156A0 IL144156A0 IL14415600A IL14415600A IL144156A0 IL 144156 A0 IL144156 A0 IL 144156A0 IL 14415600 A IL14415600 A IL 14415600A IL 14415600 A IL14415600 A IL 14415600A IL 144156 A0 IL144156 A0 IL 144156A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrazinones
- pyrido
- imidazo
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1999102082 DE19902082A1 (en) | 1999-01-20 | 1999-01-20 | New and known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, useful as phosphodiesterase 5 inhibitors for treating erectile dysfunction |
DE1999161302 DE19961302A1 (en) | 1999-12-18 | 1999-12-18 | Treatment of erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinones as phosphodiesterase inhibitors, some of which are also useful for treating cardiovascular disorders |
PCT/EP2000/000260 WO2000043392A2 (en) | 1999-01-20 | 2000-01-14 | Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144156A0 true IL144156A0 (en) | 2002-05-23 |
Family
ID=26051406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14415600A IL144156A0 (en) | 1999-01-20 | 2000-01-14 | Use of imidazo [1,5-a]-pyrido [3,2-e] -pyrazinones as medicaments |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1144410A2 (en) |
JP (1) | JP2002535330A (en) |
KR (1) | KR20010101603A (en) |
CN (1) | CN1344268A (en) |
AR (1) | AR022318A1 (en) |
AU (1) | AU2291200A (en) |
BG (1) | BG105714A (en) |
BR (1) | BR0007613A (en) |
CA (1) | CA2296224A1 (en) |
CO (1) | CO5190700A1 (en) |
CZ (1) | CZ20012627A3 (en) |
EA (1) | EA200100792A1 (en) |
EE (1) | EE200100377A (en) |
HU (1) | HUP0105132A3 (en) |
ID (1) | ID29790A (en) |
IL (1) | IL144156A0 (en) |
IS (1) | IS5987A (en) |
LT (1) | LT2001078A (en) |
LV (1) | LV12793B (en) |
NO (1) | NO20013334L (en) |
SK (1) | SK10322001A3 (en) |
TR (1) | TR200102121T2 (en) |
WO (1) | WO2000043392A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403597B1 (en) | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US6548490B1 (en) * | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
EP1461022A2 (en) * | 2001-12-17 | 2004-09-29 | ALTANA Pharma AG | Use of selective pde5 inhibitors for treating partial and global respiratory failure |
FR2835741B1 (en) * | 2002-02-12 | 2006-05-05 | Oreal | NOVEL 6-ALCOXY-2,3-DIAMINOPYRIDINE COUPLINGS USEFUL FOR DYING KERATIN FIBERS |
US6916345B2 (en) | 2002-02-12 | 2005-07-12 | L'oreal S.A. | 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres |
DE10325813B4 (en) | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxis and / or therapy in portal hypertension |
US8299083B2 (en) | 2004-08-17 | 2012-10-30 | The Johns Hopkins University | PDE5 inhibitor compositions and methods for treating cardiac indications |
KR101563103B1 (en) * | 2006-12-13 | 2015-10-23 | 아스카 세이야쿠 가부시키가이샤 | Quinoxaline derivative |
US20090143361A1 (en) * | 2007-11-30 | 2009-06-04 | Elbion Gmbh | Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 |
CN101918408A (en) | 2007-11-30 | 2010-12-15 | 惠氏有限责任公司 | Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |
IN2015DN02829A (en) | 2011-10-10 | 2015-09-11 | Lundbeck & Co As H | |
AU2013213603B2 (en) | 2012-01-26 | 2017-02-02 | H. Lundbeck A/S | PDE9 inhibitors with imidazo triazinone backbone |
JP5842640B2 (en) * | 2012-01-31 | 2016-01-13 | 株式会社東洋新薬 | Phosphodiesterase 3 inhibitor |
WO2016022825A1 (en) * | 2014-08-07 | 2016-02-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
WO2016022836A1 (en) * | 2014-08-07 | 2016-02-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
MX2018000283A (en) | 2015-07-07 | 2018-11-22 | H Lundbeck As | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5055465A (en) * | 1989-05-31 | 1991-10-08 | Berlex Laboratories, Inc. | Imidazoquinoxalinones, their aza analogs and process for their preparation |
DE19510965A1 (en) * | 1995-03-24 | 1996-09-26 | Asta Medica Ag | New pyrido / 3,2-e / pyrazinone with anti-asthmatic activity and process for their preparation |
-
2000
- 2000-01-14 EE EEP200100377A patent/EE200100377A/en unknown
- 2000-01-14 AU AU22912/00A patent/AU2291200A/en not_active Abandoned
- 2000-01-14 CZ CZ20012627A patent/CZ20012627A3/en unknown
- 2000-01-14 IL IL14415600A patent/IL144156A0/en unknown
- 2000-01-14 TR TR2001/02121T patent/TR200102121T2/en unknown
- 2000-01-14 JP JP2000594808A patent/JP2002535330A/en active Pending
- 2000-01-14 EA EA200100792A patent/EA200100792A1/en unknown
- 2000-01-14 CN CN00805307A patent/CN1344268A/en active Pending
- 2000-01-14 WO PCT/EP2000/000260 patent/WO2000043392A2/en not_active Application Discontinuation
- 2000-01-14 SK SK1032-2001A patent/SK10322001A3/en unknown
- 2000-01-14 BR BR0007613-9A patent/BR0007613A/en not_active Application Discontinuation
- 2000-01-14 EP EP00901561A patent/EP1144410A2/en not_active Withdrawn
- 2000-01-14 KR KR1020017009112A patent/KR20010101603A/en not_active Application Discontinuation
- 2000-01-14 ID IDW00200101592A patent/ID29790A/en unknown
- 2000-01-14 HU HU0105132A patent/HUP0105132A3/en unknown
- 2000-01-19 CO CO00002747A patent/CO5190700A1/en not_active Application Discontinuation
- 2000-01-19 CA CA002296224A patent/CA2296224A1/en not_active Abandoned
- 2000-01-19 AR ARP000100246A patent/AR022318A1/en unknown
-
2001
- 2001-06-29 IS IS5987A patent/IS5987A/en unknown
- 2001-07-05 NO NO20013334A patent/NO20013334L/en not_active Application Discontinuation
- 2001-07-17 BG BG105714A patent/BG105714A/en unknown
- 2001-07-19 LT LT2001078A patent/LT2001078A/en not_active Application Discontinuation
- 2001-07-19 LV LV010109A patent/LV12793B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BG105714A (en) | 2002-02-28 |
CN1344268A (en) | 2002-04-10 |
SK10322001A3 (en) | 2002-07-02 |
IS5987A (en) | 2001-06-29 |
KR20010101603A (en) | 2001-11-14 |
JP2002535330A (en) | 2002-10-22 |
NO20013334D0 (en) | 2001-07-05 |
TR200102121T2 (en) | 2002-01-21 |
EE200100377A (en) | 2002-10-15 |
EP1144410A2 (en) | 2001-10-17 |
LT2001078A (en) | 2002-08-26 |
HUP0105132A3 (en) | 2002-12-28 |
LV12793A (en) | 2002-02-20 |
LV12793B (en) | 2002-05-20 |
ID29790A (en) | 2001-10-11 |
CO5190700A1 (en) | 2002-08-29 |
CZ20012627A3 (en) | 2002-01-16 |
NO20013334L (en) | 2001-07-05 |
AR022318A1 (en) | 2002-09-04 |
AU2291200A (en) | 2000-08-07 |
BR0007613A (en) | 2001-10-30 |
HUP0105132A2 (en) | 2002-05-29 |
EA200100792A1 (en) | 2002-10-31 |
WO2000043392A2 (en) | 2000-07-27 |
WO2000043392A3 (en) | 2000-09-28 |
CA2296224A1 (en) | 2000-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202494A2 (en) | Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0203503A3 (en) | Pyrrolo[2,3-d]pirimidine compounds, pharmaceutical compositions containing them and their use | |
HUP0500332A3 (en) | Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)-one derivatives, their use and pharmaceutical compositions containing them | |
IL133959A0 (en) | Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation | |
IL134081A0 (en) | 1,2,4-triazolo [4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them | |
IL191960A (en) | Imidazo[1,5-a]pyridine derivatives and pharmaceutical compositions comprising the same | |
HUP0303350A3 (en) | Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting pharmaceutical compositions | |
HUP0204246A3 (en) | Novel thiazolo[4,5-d]pyrimidine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
IL144156A0 (en) | Use of imidazo [1,5-a]-pyrido [3,2-e] -pyrazinones as medicaments | |
NZ330988A (en) | 5h-thiazolo[3,2-a]pyrimidine derivatives used as neurological medicaments | |
WO2000012504A3 (en) | Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one | |
HUP0402018A3 (en) | 5-amino-7h-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives, their use and pharmaceutical compositions containing them | |
HUP0500328A3 (en) | Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)-one derivatives, their use and pharmaceutical compositions containing them | |
AU2002361407A1 (en) | Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof | |
IL156536A0 (en) | Pyrazolo [3,4-d] pyrimidin-4-one derivatives and pharmaceutical compositions containing the same | |
PL349364A1 (en) | Use of pyridazino[4,5-b | |
PL366858A1 (en) | Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments | |
HUP0202624A3 (en) | Pyrazolo[4,3-d]pyrimidine-derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0102981A3 (en) | Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof | |
HUP0105054A3 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation | |
HUP0003118A3 (en) | Use of 2,7-substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives for production of pharmaceutical compositions | |
HU0103075D0 (en) | Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one derivatives and intermediates thereof | |
MXPA03008894A (en) | Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments. | |
HU0003979D0 (en) | Process for the preparation of 3-pyridylsulphonil-pyrazolo[4,3-d] pyrimidin-7-one derivatives and intermediates thereof | |
HUP0203579A3 (en) | Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition and pharmaceutical compositions containing them and their use |